secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001104659-25-015224
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics grants 50,000 CEO options and 30,000 options each to three non-employee directors
--------------------------------------------------------------------------------

- CEO Juan Vera awarded 50,000 stock options vesting annually over three years under 2020 Plan.
- Non-employee directors David Eansor, Katherine Knobil, and Steven Elms each receive 30,000 options with same vesting.
- Awards approved by Compensation Committee and Board on February 12, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925015224/0001104659-25-015224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925015224/tm257101d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-015224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer